Cargando…
Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin
The aim of this study was to investigate pharmaceutical potentialities of a polymeric microparticulate drug delivery system for modulating the drug profile of poorly water-soluble quercetin. In this research work two cost effective polymers sodium alginate and chitosan were used for entrapping the m...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834692/ https://www.ncbi.nlm.nih.gov/pubmed/27134546 http://dx.doi.org/10.1016/j.jsps.2015.01.007 |
_version_ | 1782427528905883648 |
---|---|
author | Hazra, Moumita Dasgupta Mandal, Dalia Mandal, Tamal Bhuniya, Saikat Ghosh, Mallika |
author_facet | Hazra, Moumita Dasgupta Mandal, Dalia Mandal, Tamal Bhuniya, Saikat Ghosh, Mallika |
author_sort | Hazra, Moumita |
collection | PubMed |
description | The aim of this study was to investigate pharmaceutical potentialities of a polymeric microparticulate drug delivery system for modulating the drug profile of poorly water-soluble quercetin. In this research work two cost effective polymers sodium alginate and chitosan were used for entrapping the model drug quercetin through ionic cross linking method. In vitro drug release, swelling index, drug entrapment efficiency, Fourier Transforms Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD) and Differential Scanning Calorimetric (DSC) studies were also done for physicochemical characterization of the formulations. Swelling index and drug release study were done at a pH of 1.2, 6.8 and 7.4 to evaluate the GI mimetic action which entails that the swelling and release of the all the Formulation1 (F1), Formulation2 (F2) and Formulation3 (F3) at pH 1.2 were minimal confirming the prevention of drug release in the acidic environment of stomach. Comparatively more sustained release was seen from the formulations F2 & F3 at pH 6.8 and pH 7.4 after 7 h of drug release profiling. Drug entrapment efficiency of the formulations shows in F1 (D:C:A = 2:5:30) was approximately 70% whereas the increase in chitosan concentration in F2 (D:C:A = 2:10:30) has shown an entrapment efficiency of 81%. But the comparative further increase of chitosan concentration in F3 (D:C:A = 2:15:30) has shown a entrapment of 80% which is not having any remarkable difference from F2. The FTIR analysis of drug, polymers and the formulations indicated the compatibility of the drug with the polymers. The smoothness of microspheres in F2 & F3 was confirmed by Scanning Electron Microscopy (SEM). However F1 microsphere has shown more irregular shape comparatively. The DSC studies indicated the absence of drug-polymer interaction in the microspheres. Our XRD studies have revealed that when pure drug exhibits crystalline structure with less dissolution profile, formulated microparticles can help us to obtain amorphous form of the same drug that is likely to have more dissolution property. The findings of the study suggest that the microsphere formulations were a promising carrier for quercetin delivery and can be considered as a favorable oral controlled release dosage form for hydrophobic drug quercetin. |
format | Online Article Text |
id | pubmed-4834692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-48346922016-04-29 Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin Hazra, Moumita Dasgupta Mandal, Dalia Mandal, Tamal Bhuniya, Saikat Ghosh, Mallika Saudi Pharm J Original Article The aim of this study was to investigate pharmaceutical potentialities of a polymeric microparticulate drug delivery system for modulating the drug profile of poorly water-soluble quercetin. In this research work two cost effective polymers sodium alginate and chitosan were used for entrapping the model drug quercetin through ionic cross linking method. In vitro drug release, swelling index, drug entrapment efficiency, Fourier Transforms Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD) and Differential Scanning Calorimetric (DSC) studies were also done for physicochemical characterization of the formulations. Swelling index and drug release study were done at a pH of 1.2, 6.8 and 7.4 to evaluate the GI mimetic action which entails that the swelling and release of the all the Formulation1 (F1), Formulation2 (F2) and Formulation3 (F3) at pH 1.2 were minimal confirming the prevention of drug release in the acidic environment of stomach. Comparatively more sustained release was seen from the formulations F2 & F3 at pH 6.8 and pH 7.4 after 7 h of drug release profiling. Drug entrapment efficiency of the formulations shows in F1 (D:C:A = 2:5:30) was approximately 70% whereas the increase in chitosan concentration in F2 (D:C:A = 2:10:30) has shown an entrapment efficiency of 81%. But the comparative further increase of chitosan concentration in F3 (D:C:A = 2:15:30) has shown a entrapment of 80% which is not having any remarkable difference from F2. The FTIR analysis of drug, polymers and the formulations indicated the compatibility of the drug with the polymers. The smoothness of microspheres in F2 & F3 was confirmed by Scanning Electron Microscopy (SEM). However F1 microsphere has shown more irregular shape comparatively. The DSC studies indicated the absence of drug-polymer interaction in the microspheres. Our XRD studies have revealed that when pure drug exhibits crystalline structure with less dissolution profile, formulated microparticles can help us to obtain amorphous form of the same drug that is likely to have more dissolution property. The findings of the study suggest that the microsphere formulations were a promising carrier for quercetin delivery and can be considered as a favorable oral controlled release dosage form for hydrophobic drug quercetin. Elsevier 2015-09 2015-01-10 /pmc/articles/PMC4834692/ /pubmed/27134546 http://dx.doi.org/10.1016/j.jsps.2015.01.007 Text en © 2015 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Hazra, Moumita Dasgupta Mandal, Dalia Mandal, Tamal Bhuniya, Saikat Ghosh, Mallika Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin |
title | Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin |
title_full | Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin |
title_fullStr | Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin |
title_full_unstemmed | Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin |
title_short | Designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin |
title_sort | designing polymeric microparticulate drug delivery system for hydrophobic drug quercetin |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834692/ https://www.ncbi.nlm.nih.gov/pubmed/27134546 http://dx.doi.org/10.1016/j.jsps.2015.01.007 |
work_keys_str_mv | AT hazramoumita designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin AT dasguptamandaldalia designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin AT mandaltamal designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin AT bhuniyasaikat designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin AT ghoshmallika designingpolymericmicroparticulatedrugdeliverysystemforhydrophobicdrugquercetin |